While Quercetin decreased Survivin levels in thyroid cancer cells, but not in CD18 pancreatic cancer cells, co-treatment with JQ1 and Quercetin resulted in pronounced reduction in Survivin levels in both thyroid and pancreatic cancer cells (Figure 4B). Here, BIRC5 is linked to pancreatic neoplasm.